494773-21-6

Basic information

• Product Name: Morpholine, 4-[(1S)-1-(4-bromophenyl)ethyl]-
• CAS NO: 494773-21-6
• Molecular Formula: C12H16BrNO
• Molecular Weight: 270.169
• Mol File: 494773-21-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Morpholine, 4-[(1S)-1-(4-bromophenyl)ethyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Morpholine, 4-[(1S)-1-(4-bromophenyl)ethyl]-(494773-21-6)
• EPA Substance Registry System: Morpholine, 4-[(1S)-1-(4-bromophenyl)ethyl]-(494773-21-6)

Safety Data

• Hazardous Substances Data: 494773-21-6(Hazardous Substances Data)

Upstream product

• 5414-19-7 1,1'-oxybis(2-bromo-ethane) 
• 27298-97-1 (S)-1-(4-bromophenyl)ethylamine 
• 84499-77-4 (S)-α-(p-bromophenyl)ethylamine hydrochloride 
• 73183-34-3 bis(pinacol)diborane 
• 111-44-4 3-oxa-1,5-dichloropentane 

Downstream Products

• 1373010-62-8 (1R,2S)-2-(3-((E)-4-((S)-1-morpholinoethyl)styryl)-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one hydrochloride 

Relevant articles and documents

PLK-4 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

The invention is directed to a compound represented by the following Structural Formula (I) and (II) and pharmaceutically acceptable salts thereof: (Formula (I)); (Formula (IV)). Compounds represented by this structural formula are kinase inhibitors and are, therefore, disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.